Abstract
The past 2 years have provided exciting progress in elucidating the molecular basis of renal cancer. Work on the von Hippel-Lindau tumor suppressor, pVHL, in clear-cell renal cancer is already suggesting new potential therapies, and should have important implications in the pathogenesis of renal cystic disease and tumor angiogenesis. In addition, study of the Wilms' tumor suppressor, WT1, is revealing much about the pathogenesis of Wilms' tumor, urogenital development, and glomerular podocyte biology. c-met, the gene encoding the hepatocyte growth factor receptor, has recently been identified as a causative gene for hereditary papillary renal cancer. This review will highlight these and other new molecular advances in the renal cancer field.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Adenocarcinoma, Clear Cell / genetics
-
Carcinoma, Papillary / genetics
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism
-
Genes, Tumor Suppressor
-
Genes, Wilms Tumor
-
Humans
-
Kidney Neoplasms / genetics*
-
Kidney Neoplasms / metabolism
-
Ligases*
-
Proteins / genetics
-
Proto-Oncogene Proteins c-met / genetics
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
-
Tumor Suppressor Proteins*
-
Ubiquitin-Protein Ligases*
-
Von Hippel-Lindau Tumor Suppressor Protein
-
WT1 Proteins
-
Wilms Tumor / genetics
-
Wilms Tumor / metabolism
Substances
-
DNA-Binding Proteins
-
Proteins
-
Transcription Factors
-
Tumor Suppressor Proteins
-
WT1 Proteins
-
Ubiquitin-Protein Ligases
-
Von Hippel-Lindau Tumor Suppressor Protein
-
Proto-Oncogene Proteins c-met
-
Ligases
-
VHL protein, human